All News
Topical therapies take centre stage
Topical treatments have so often been the low level “sure you can try this” option. However there are exciting data that these approaches may become part of our main armamentarium.
Read ArticleReal World Data on Urate Lowering Therapy
Urate lowering therapy (ULT) is the backbone therapy for long-term gout treatment and maintenance, but real-world gout management is often imperfect and suboptimal.
Read ArticleEric Dein ericdeinmd ( View Tweet)
Eric Dein ericdeinmd ( View Tweet)
David Liew drdavidliew ( View Tweet)
Eric Dein ericdeinmd ( View Tweet)
EULAR 2022 – Day 2 Report
A full day at EULAR with oral and poster presentations of abstracts in the morning and a plethora of scientific (review) sessions in the afternoon. The latter covering topics like sarcoidosis, Still’s disease, fibromyalgia, back pain, sarcopenia, APS, IgG4 and imaging in vasculitis.
Read ArticleLinks:
Links:
Links:
Links:
Links:
Recommendations – Good & Bad (5.27.2022)
Dr. Jack Cush reviews the news, regulatory updates and journal reports from the past week on RheumNow.com. This week gout worries, mortality risks, measuring anti-drug antibodies and a better way in lupus?
Read ArticleCardiovascular Risk in Calcium Pyrophosphate Deposition Disease
The cardiovascular (CV) risks of inflammation and gout are well known, but until recently hasn't been tied to calcium pyrophosphate deposition (CPPD) disease. A recent EHR study shows that acute CPPD crystal arthritis was significantly associated with elevated risks for non-fatal CV events.
Read ArticleLinks:
Links:
Is Gout Protective Against Dementia?
People with gout appeared less likely to develop dementia than age- and sex-matched peers, a database study from Korea found.
Read Article